Jul 102018
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MD – Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on infectious disease, today announced it has appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board, effective immediately.… => Read full post

Altimmune appoints Dr Mitchell Sayare as Executive Chairman of the Board

From:: Altimmune appoints Dr Mitchell Sayare as Executive Chairman of the Board

Sorry, the comment form is closed at this time.

%d bloggers like this: